CIK 0001661181
- Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- 4 Grant or award Director acquired 65,737 shares (grant or award)
- 4 Grant or award Director acquired 65,737 shares (grant or award)
- 4 Grant or award Director acquired 65,737 shares (grant or award)
- 4 Grant or award Director acquired 65,737 shares (grant or award)
- 4 Shares withheld for taxes VP Health Policy & Contracting gave up 1,966 shares (to pay taxes)
- 4 Shares withheld for taxes VP and General Counsel gave up 4,400 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 4,145 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 5,535 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,459 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 25,304 shares (to pay taxes)
- 4 Open-market buy 10% owner bought 6,000 shares at an average $2.57 ($15,390)
- 4 Option exercise Chief Commercial Officer acquired 805 shares (option exercise)
- 4 Open-market buy Director bought 3,000 shares at $4.76 ($14,265)
- 4 Open-market buy Director bought 5,000 shares at $4.80 ($24,000)
- 4 Option exercise President and CEO acquired 505,050 shares (option exercise)
- 4 Open-market sale 10% owner sold 30,000 shares at an average $4.89 ($146,836)
- 4 Open-market sale 10% owner sold 30,000 shares at an average $4.89 ($146,836)
- 4 Open-market sale 10% owner sold 170,000 shares at an average $5.43 ($923,300)
- 4 Open-market sale 10% owner sold 170,000 shares at an average $5.43 ($923,300)
- 4 Open-market sale President and CEO sold 247,334 shares at an average $5.55 ($1,372,643)
Page 7 of 17 · 321 filings